Correlation Between CSL and PsyBio Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CSL and PsyBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CSL and PsyBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CSL and PsyBio Therapeutics Corp, you can compare the effects of market volatilities on CSL and PsyBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CSL with a short position of PsyBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of CSL and PsyBio Therapeutics.

Diversification Opportunities for CSL and PsyBio Therapeutics

0.59
  Correlation Coefficient

Very weak diversification

The 3 months correlation between CSL and PsyBio is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding CSL and PsyBio Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PsyBio Therapeutics Corp and CSL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CSL are associated (or correlated) with PsyBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PsyBio Therapeutics Corp has no effect on the direction of CSL i.e., CSL and PsyBio Therapeutics go up and down completely randomly.

Pair Corralation between CSL and PsyBio Therapeutics

Assuming the 90 days horizon CSL is expected to under-perform the PsyBio Therapeutics. But the pink sheet apears to be less risky and, when comparing its historical volatility, CSL is 38.92 times less risky than PsyBio Therapeutics. The pink sheet trades about -0.02 of its potential returns per unit of risk. The PsyBio Therapeutics Corp is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  5.29  in PsyBio Therapeutics Corp on October 16, 2024 and sell it today you would lose (5.28) from holding PsyBio Therapeutics Corp or give up 99.81% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy99.8%
ValuesDaily Returns

CSL  vs.  PsyBio Therapeutics Corp

 Performance 
       Timeline  
CSL 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CSL has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
PsyBio Therapeutics Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PsyBio Therapeutics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's fundamental drivers remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

CSL and PsyBio Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CSL and PsyBio Therapeutics

The main advantage of trading using opposite CSL and PsyBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CSL position performs unexpectedly, PsyBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PsyBio Therapeutics will offset losses from the drop in PsyBio Therapeutics' long position.
The idea behind CSL and PsyBio Therapeutics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Money Managers
Screen money managers from public funds and ETFs managed around the world
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites